Video Display CEO Buys 5.7K Shares and 4 Insider Buys to Note

Baker Mark Robert who is CEO at Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), bought 1,215 shares at $2.82 per share for a total value of $3,429. The shares recently traded at $2.94, up $0.12, or 4.26% since the insider buy.

Current Price $2.94


Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

More Articles About: